Active, not recruitingNCT05460715
The Medacta Quadra-P Anteverted Study
Studying Avascular necrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medacta International SA
- Intervention
- Quadra P anteverted(device)
- Enrollment
- 300 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2021 – 2032
Study locations (1)
- Istituto Ortopedico Franco Scalabrino, Messina, Messina, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05460715 on ClinicalTrials.govOther trials for Avascular necrosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07286513Persona SoluTion PPS Femur PMCFZimmer Biomet
- RECRUITINGPHASE2NCT06016634Alendronate for Osteonecrosis in Adults With Sickle Cell DiseaseUniversity of California, Davis
- RECRUITINGNANCT06823089Early Feasibility Study of Cartilage Defect RepairCytex Therapeutics, Inc.
- RECRUITINGNANCT06631638EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))DePuy Orthopaedics
- RECRUITINGNCT07104279Z1 Hip System: Post-Market Clinical Follow Up StudyZimmer Biomet
- ENROLLING BY INVITATIONNCT07150221MDR Vivacit-E Elevated StudyZimmer Biomet
- RECRUITINGNANCT07104084Influence of Antiseptic Washes on Wound Healing Complications After THAF. Johannes Plate
- ENROLLING BY INVITATIONNANCT07255768Comparison of the Efficacy of Pericapsular Nerve Group Block Alone Versus Pericapsular Nerve Group Block Combined With Superior Cluneal and Superior Gluteal Nerve Blocks in Patients Undergoing Hip SurgeryAtaturk University